Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

2.110

+0.050 (2.43%)

At close: Oct 23, 2026, 4:00 PM EDT

2.140

+0.030 (1.42%)

Pre-market: Oct 26, 2026, 7:43 AM EDT

PACB Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	159.27	160.01	154.01	200.52	128.3	130.51
Revenue Growth	2.02%	3.89%	-23.19%	56.29%	-1.69%	65.43%
Gross Profit	46.86	54.85	47.67	58.2	53.47	59.17
Operating Income	-177.54	-551.66	-290.66	-310.37	-304.82	-178.16
Net Income	-131.39	-546.38	-309.85	-306.74	-314.25	-181.22
Earnings Per Share	-0.43	-1.82	-1.13	-1.21	-1.40	-0.89
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Europe, Middle East and Africa	50.54	44.05	34.59	40.66	22.6	30.27
Asia Pacific	35.62	43.16	40.71	54.45	36.15	35.72
United States of America	-	69.7	75.3	100.5	66.8	-
Americas (excl. United States)	-	3.1	3.41	4.91	2.76	-
Total	159.27	160.01	154.01	200.52	128.3	130.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	236.87	279.51	389.93	631.42	772.32	1,044
Total Debt	709.13	702.42	672.43	933.93	948.48	955.36
Net Cash (Debt)	-472.25	-422.92	-282.5	-302.51	-176.16	89.05
Net Cash Growth	-	-	-	-	-	-67.83%
Net Cash Per Share	-1.55	-1.41	-1.03	-1.19	-0.78	0.44

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-118.05	-111.21	-206.06	-259.17	-263.21	-111.18
Capital Expenditures	-5.37	-2.71	-6.19	-8.84	-16.75	-5.93
Free Cash Flow	-123.42	-113.92	-212.25	-268.02	-279.96	-117.11
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	29.42%	34.28%	30.95%	29.02%	41.68%	45.33%
Operating Margin	-111.47%	-344.78%	-188.73%	-154.78%	-237.58%	-136.51%
Pretax Margin	-81.97%	-341.28%	-200.98%	-158.67%	-244.92%	-210.61%
Profit Margin	-82.49%	-341.47%	-201.18%	-152.97%	-244.93%	-138.85%
FCF Margin	-77.49%	-71.20%	-137.81%	-133.66%	-218.20%	-89.73%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	4.12	3.53	3.50	13.08	14.42	34.58